TEJNAKSHHealthcare Service Provider
Tejnaksh Healthcare Ltd — Profit & Loss Statement
₹11.93
-5.89%
Tejnaksh Healthcare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.02 Cr | -0.05 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.26 | 0.29 | 0.25 | — |
| Normalized EBITDA | 4.48 Cr | 3.93 Cr | 4.06 Cr | 5.02 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -0.06 Cr | -0.19 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -0.06 Cr | -0.19 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 2.33 Cr | 1.78 Cr | 1.68 Cr | 2.72 Cr | — |
| Reconciled Depreciation | 0.91 Cr | 0.91 Cr | 0.87 Cr | 0.65 Cr | — |
| Reconciled Cost Of Revenue | 1.29 Cr | 1.27 Cr | 1.41 Cr | 1.41 Cr | — |
| EBITDA | 4.48 Cr | 3.93 Cr | 3.99 Cr | 4.83 Cr | — |
| EBIT | 3.57 Cr | 3.02 Cr | 3.12 Cr | 4.16 Cr | — |
| Net Interest Income | -0.38 Cr | -0.64 Cr | -0.49 Cr | -0.42 Cr | — |
| Interest Expense | 0.38 Cr | 0.64 Cr | 0.61 Cr | 0.40 Cr | — |
| Normalized Income | 2.33 Cr | 1.78 Cr | 1.73 Cr | 2.87 Cr | — |
| Net Income From Continuing And Discontinued Operation | 2.33 Cr | 1.78 Cr | 1.68 Cr | 2.72 Cr | — |
| Total Expenses | 9.73 Cr | 9.46 Cr | 8.60 Cr | 8.16 Cr | — |
| Diluted NI Availto Com Stockholders | 2.33 Cr | 1.78 Cr | 1.68 Cr | 2.72 Cr | — |
| Net Income Common Stockholders | 2.33 Cr | 1.78 Cr | 1.68 Cr | 2.72 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 2.33 Cr | 1.78 Cr | 1.68 Cr | 2.72 Cr | — |
| Minority Interests | 0.10 Cr | 0.01 Cr | -0.11 Cr | -0.09 Cr | — |
| Net Income Including Noncontrolling Interests | 2.23 Cr | 1.76 Cr | 1.79 Cr | 2.81 Cr | — |
| Net Income Continuous Operations | 2.23 Cr | 1.76 Cr | 1.79 Cr | 2.81 Cr | — |
| Tax Provision | 0.96 Cr | 0.61 Cr | 0.72 Cr | 0.95 Cr | — |
| Pretax Income | 3.19 Cr | 2.38 Cr | 2.51 Cr | 3.76 Cr | — |
| Other Non Operating Income Expenses | 0.40 Cr | 0.31 Cr | 0.17 Cr | 0.08 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -0.06 Cr | -0.19 Cr | — |
| Net Non Operating Interest Income Expense | -0.38 Cr | -0.64 Cr | -0.49 Cr | -0.42 Cr | — |
| Interest Expense Non Operating | 0.38 Cr | 0.64 Cr | 0.61 Cr | 0.40 Cr | — |
| Operating Income | 3.16 Cr | 2.71 Cr | 2.89 Cr | 4.29 Cr | — |
| Operating Expense | 8.45 Cr | 8.19 Cr | 7.19 Cr | 6.75 Cr | — |
| Other Operating Expenses | 6.01 Cr | 5.92 Cr | 1.93 Cr | 1.92 Cr | — |
| Depreciation And Amortization In Income Statement | 0.91 Cr | 0.91 Cr | 0.87 Cr | 0.67 Cr | — |
| Depreciation Income Statement | 0.91 Cr | 0.91 Cr | 0.87 Cr | 0.67 Cr | — |
| Gross Profit | 11.61 Cr | 10.91 Cr | 10.08 Cr | 11.03 Cr | — |
| Cost Of Revenue | 1.29 Cr | 1.27 Cr | 1.41 Cr | 1.41 Cr | — |
| Total Revenue | 12.90 Cr | 12.18 Cr | 11.49 Cr | 12.45 Cr | — |
| Operating Revenue | 12.90 Cr | 12.18 Cr | 11.49 Cr | 12.45 Cr | — |
| Interest Income | — | 0.21 Cr | 0.13 Cr | 0.06 Cr | 0.06 Cr |
| Rent Expense Supplemental | — | 4000.00 | 83000.00 | 93000.00 | 0.00 |
| Diluted Average Shares | — | 2.04 Cr | 2.03 Cr | 2.03 Cr | 2.04 Cr |
| Basic Average Shares | — | 2.04 Cr | 2.03 Cr | 2.03 Cr | 2.04 Cr |
| Diluted EPS | — | 0.87 | 0.83 | 1.34 | 1.01 |
| Basic EPS | — | 0.87 | 0.83 | 1.34 | 1.01 |
| Write Off | — | 0.55 Cr | 0.06 Cr | 0.15 Cr | 0.04 Cr |
| Total Other Finance Cost | — | 0.02 Cr | 0.01 Cr | 0.08 Cr | 0.02 Cr |
| Interest Income Non Operating | — | 0.21 Cr | 0.13 Cr | 0.06 Cr | 0.06 Cr |
| Amortization | — | 4000.00 | 42000.00 | 0.00 | 54000.00 |
| Selling General And Administration | — | 3.72 Cr | 3.24 Cr | 3.06 Cr | 3.59 Cr |
| Selling And Marketing Expense | — | 0.06 Cr | 0.03 Cr | 0.01 Cr | 0.01 Cr |
| General And Administrative Expense | — | 3.66 Cr | 3.21 Cr | 3.05 Cr | 3.58 Cr |
| Rent And Landing Fees | — | 4000.00 | 83000.00 | 93000.00 | 0.00 |
| Other Special Charges | — | — | — | 0.04 Cr | 56000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Tejnaksh Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.